Sunitix is an oncology product. It is used to treat cancer by preventing the activity of a special group of proteins which are known to be involved in the growth and spread of cancer cells.
Sunitix will only be prescribed by a doctor with experienced in the use of anti-cancer medicinal products.
Gastrointestinal stromal tumour (GIST)
Sunitinib is effective & safe in patients with advanced gastrointestinal stromal tumour after failure of imatinib treatment due to resistance or intolerance.
Sunitix is used for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (GIST) in adults after failure of imatinib treatment due to resistance or intolerance.
Metastatic renal cell carcinoma
Sunitix is used for the treatment of advanced/metastatic renal cell carcinoma (MRCC) in adults.
Pancreatic neuroendocrine tumours (pNET)
Sunitix is used for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pNET) with disease progression in adults.
It is limited to use Sunitinib as the first line treatment.